Eli Lilly (LLY): VA awarded $52K
VA awarded Eli Lilly a contract with $52K committed so far.
- $52K
- committed so far
- $261K
- maximum it could reach
- Signed
- May 15, 2026
- Updated
- May 15, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 2, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
- Jan 2, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
- Feb 13, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
- Mar 13, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
- Apr 1, 2026FDAFDA drug approval: Foundayo
- Apr 2, 2026Congress · 1 personMembers of Congress: 2 purchases
- Apr 8, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Apr 14, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
- Apr 20, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.7%
- Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
- May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.5%
- May 6, 2026Insider · 1 personInsiders: 2 sales (~$15.8M)
- May 15, 2026 · this disclosureFederal contract · $52K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $52K obligated to date
What came next
- Jun 9, 2026FDAFDA drug approval: Ebglyss
- Jun 10, 2026Insider · Their largest sale since 2022Officer sold ~$2.88M of LLY shares in the open market
- Jun 10, 2026Congress · 1 personMembers of Congress: 2 purchases
- Jul 1, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
- Jul 10, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
- Jul 13, 2026FDAFDA drug approval: Verzenio
- Jul 14, 2026FDAFDA drug approval: Retevmo
- Jul 14, 2026FDAFDA drug approval: Retevmo
- Jul 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.6%
- Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 7, 2026InsiderOfficer sold ~$5.95M of LLY shares in the open market
- Aug 10, 2026Insider · Their largest sale since 2014Officer sold ~$2.37M of LLY shares in the open market
- Aug 17, 2026Federal contract · $5K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $4.5K obligated to date
- Aug 17, 2026Insider · Their largest sale since 2022Officer sold ~$7.64M of LLY shares in the open market
- Aug 26, 2026FDAFDA drug approval: Zepbound
- Aug 27, 2026FDAFDA drug approval: Mounjaro
- Aug 27, 2026FDAFDA drug approval: Mounjaro
How to read USAspending.gov award record
The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.
Full guide: Contract ceiling vs obligated amount: the difference
What else is on file for Eli Lilly
For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.
How this filing works
Explore the data
Common questions
What federal contract did Eli Lilly (LLY) receive?
VA awarded Eli Lilly a contract with $52K committed so far. Could reach $261K.
When did it happen, and when was it made public?
Signed: May 15, 2026. Updated: May 15, 2026.
Is the contract value money the company has received?
No. The award record gives the amount committed so far and a ceiling the contract may reach. Neither is revenue: the company is paid as the work is delivered, and a contract can be cut short.
Where does this information come from?
From the USAspending.gov award record, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Eli Lilly recently?
For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the LLY page.
Does this mean LLY stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Eli Lilly
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 13, 2026
- House Clerk periodic transaction reportNov 12, 2026
- House Clerk periodic transaction reportNov 12, 2026
- House Clerk periodic transaction reportNov 10, 2026
Everything OQRO holds on this company is on its LLY page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
